Related by context. All words. (Click for frequent words.) 56 remission 54 Remissions 47 Remission 46 adjuvant tamoxifen 46 Filep Karma 45 complete remissions 45 Bali Kerobokan Prison 45 lenalidomide dexamethasone 44 TKIs 44 tumor regressions 44 myeloablative 44 heavily pretreated patients 44 relapses 43 Dedi Sutardi 43 custodial sentences 43 allogeneic SCT 43 azacitidine 43 metastatic kidney 43 Relapses 43 cytogenetic responses 43 androgen suppression 43 androgen deprivation 43 curative treatments 43 BEXXAR therapeutic regimen 42 L DOPA 42 Cladribine tablets 42 neutropenic patients 42 amnesties 42 histologies 42 serologically active SLE 42 sentences 42 potent antiretroviral therapy 42 durable remissions 42 chemotherapeutic regimens 42 tumor regression 42 Cipinang prison 42 Hematologic toxicity 42 Cipinang Prison 42 taxane chemotherapy 42 DMARD therapy 42 relapsing multiple sclerosis 42 lymph node dissection 42 anakinra 42 epirubicin 41 tumor resection 41 corticosteroid therapy 41 allogeneic transplantation 41 relapsed AML 41 decitabine 41 uric acid lowering 41 chemotherapy regimens 41 debulking surgery 41 canakinumab 41 cytogenetic response 41 determinate sentence 41 dosing intervals 41 tamoxifen therapy 41 TRAIL induced apoptosis 41 interferon therapy 41 postoperative chemotherapy 41 HSCT 41 several volcanos smoldering 41 splenectomized patients 41 curative resection 41 imatinib therapy 41 ACZ# 41 relapsed MM 41 indeterminate sentences 41 underwent liver transplantation 41 standard chemotherapy regimens 41 PegIFN RBV 41 basal cell nevus syndrome 41 intensity allogeneic stem 41 cranial irradiation 41 cytotoxic chemotherapy 41 DMARD 41 surgical debulking 41 heavily pretreated 41 methotrexate therapy 41 rechallenge 41 adjuvant radiation 41 topotecan 41 dosage regimens 40 symptom flare ups 40 chemotherapy docetaxel 40 APTIVUS r 40 hepatic encephalopathy HE 40 inprisonment 40 chemoradiotherapy 40 chronic lymphocytic leukemia CLL 40 Anti retroviral drugs 40 relapsed SCLC 40 androgen blockade 40 psychotic disorders 40 reincarceration 40 Lucentis injections 40 Ilham Djaya 40 ipsilateral stroke 40 anti leukemic 40 L dopa 40 remitting MS 40 incarceration 40 PNH patients 40 virologic response 40 CHOP chemotherapy 40 CCyR 40 lenalidomide Revlimid R 40 ALND 40 samalizumab 40 cytoreduction 40 unescorted temporary 40 advanced carcinoid 40 anthracycline containing 40 recurrent GBM 40 Adriamycin mainstay 40 MMP inhibitors 40 relapsed ovarian cancer 40 virological response 40 RBC transfusions 40 ribavirin therapy 40 overlapping toxicities 40 preoperative chemotherapy 40 levodopa therapy 39 pCR 39 weekly intravenous infusions 39 sulfasalazine 39 stem cell transplantations 39 severe exacerbations 39 Cipinang Penitentiary 39 alkylating agent 39 molecular remissions 39 relapse 39 reperfusion therapy 39 Cell Lymphoma CTCL 39 Hodgkin lymphomas 39 Akt activation 39 Gleevec imatinib 39 hematologic 39 antiandrogens 39 NPM1 mutations 39 curative therapy 39 progression TTP 39 nonhereditary 39 prior chemotherapy regimens 39 sustained virologic response 39 Galungan 39 antiretroviral ARV therapy 39 Trastuzumab 39 immunosuppressive medication 39 opioid analgesia 39 rTMS 39 FOLFIRINOX 39 hormone refractory 39 trastuzumab Herceptin ® 39 Gleevec resistant 39 pramipexole 39 adjuvant radiotherapy 39 immunosuppression therapy 39 pardons 39 ethosuximide 39 axonal damage 39 methotrexate monotherapy 39 Imiquimod 39 R0 resection 39 subcutaneous injections 39 PEGPH# 39 adalimumab 39 herceptin 39 myeloproliferative neoplasms 39 ritonavir boosted 39 taxane refractory 39 chemo resistant 39 nephrotoxicity 39 Bali Kerobokan jail 39 chemoradiation 39 leukemia ALL 39 biochemical relapse 39 Yusak Pakage 39 mg kg dose 39 EGFRIs 39 rimonabant #mg 39 Surgical resection 39 mesalamine granules 39 non custodial sentences 39 RAPTIVA 39 exogenous insulin 39 IFN alfa 39 treatment 39 androgen ablation 39 intravenous bisphosphonates 38 lipid lowering therapy 38 trabectedin 38 LHRH agonists 38 AGILECT R 38 CIMZIA TM 38 docetaxel chemotherapy 38 reconviction 38 indolent lymphomas 38 8mg/kg 38 parole ineligibility 38 clinically localized prostate 38 hematological toxicity 38 imprisonment 38 #mg/m# [002] 38 haematologic 38 CD# + [001] 38 Glivec imatinib 38 unescorted absences 38 bendamustine 38 EXJADE 38 commutation 38 Natalizumab 38 AGILECT ® 38 abiraterone acetate 38 TNF antagonist 38 idarubicin 38 dasatinib 38 WBPA 38 telomerase activity 38 temsirolimus 38 Etanercept 38 antiepileptic medications 38 concomitant antibiotics 38 PSADT 38 antiarrhythmic drugs 38 non progressors 38 resminostat 38 FOLPI regimen 38 conventional chemotherapeutic agents 38 IV NSCLC 38 cranial radiation 38 FluCAM 38 selegiline 38 dose cytarabine 38 autologous transplants 38 virologic suppression 38 tumor shrinkage 38 liver metastasis 38 Advagraf 38 briakinumab 38 neuroleptics 38 transplanted islets 38 KRAS mutant tumors 38 acute gout flares 38 coinfected patients 38 granting pardons 38 imatinib Gleevec 38 Ph + 38 doxorubicin docetaxel 38 reprieves 38 non hematological toxicities 38 nephrotoxic drugs 38 alefacept 38 5FU 38 reconvicted within 38 interferon alfa 38 etoposide 38 placebo dexamethasone 38 tocilizumab 38 androgen depletion 38 virological suppression 38 induction regimen 38 receiving highly emetogenic 38 #mg dose [001] 38 doxorubicin cyclophosphamide 38 talabostat 38 immunosuppression 38 DMARDs 38 cisplatin chemotherapy 38 DAPT 38 chemotherapeutic agents 38 severe neutropenia 38 unsentenced prisoners 38 timepoints 38 temozolomide 38 DOXIL 38 trastuzumab Herceptin 38 telomerase inhibition 38 neurologic progression 38 Awaluddin 38 huN# DM1 38 immune modulating 38 ALT flares 38 induce remission 38 Ba'asyir 38 mitoxantrone 38 taxanes 38 Zevalin consolidation 38 oral FTY# 38 allogeneic stem cell 38 paliperidone palmitate 38 nonviolent felonies 38 bowel resection 38 leukemia myeloma 38 octreotide LAR 38 nab paclitaxel 38 IFN α 37 royal pardon 37 titration phase 37 adjuvant cisplatin 37 nonmyeloablative 37 immune suppressing 37 onsets 37 rituximab 37 cytotoxic therapies 37 relapsing remitting 37 hepatocellular carcinomas 37 care regimens CCR 37 Abu Bakar Ba'asyir 37 reincarcerated 37 androgen ablation therapy 37 dosing schedules 37 leukemia AML 37 Interferon alpha 37 IV tPA 37 medullary thyroid cancer 37 FOLFOX4 37 cidofovir 37 reprieve 37 dose titration 37 TACE 37 aPTT 37 MACCE 37 seropositive patients 37 electroconvulsive therapy 37 differentiated thyroid 37 Mitoxantrone 37 adverse cytogenetics 37 neoadjuvant therapy 37 bevacizumab Avastin 37 p#HER# positive 37 VIDAZA 37 nadolol 37 Scale EDSS 37 Home Detention Curfew 37 SJIA 37 partial remissions 37 atacicept 37 recurrent glioblastoma multiforme 37 pegfilgrastim 37 nucleoside analogs 37 prostate adenocarcinoma 37 lymphadenectomy 37 demethylation 37 pegylated liposomal doxorubicin 37 hepatic resection 37 lung carcinomas 37 PFAPA 37 cis retinoic acid 37 Paraplatin ® carboplatin 37 PTLD 37 albumin bound paclitaxel 37 pyrazinamide 37 Jerudong Prison 37 repolarization 37 Ph + ALL 37 erlotinib Tarceva 37 neoadjuvant 37 Maafushi 37 Ramzan fasting 37 NMDA antagonist 37 adalimumab etanercept 37 certolizumab 37 IFNs 37 Psychosocial interventions 37 Sutent sunitinib 37 tumor lysis syndrome 37 myelosuppressive 37 refractory indolent NHL 37 C1 INH deficiency 37 conventional DMARDs 37 renal cell carcinomas 37 Traficet EN 37 IMA# 37 inpatient hospitalizations 37 stage IIIB IV 37 gene rearrangements 37 endoscopic remission 37 Revlimid lenalidomide 37 viral suppression 37 Hydroxyurea 37 paclitaxel Taxol ® 37 Seliciclib 37 fluorouracil 37 remission induction 37 sentence 37 adriamycin 37 dose colchicine 37 TRPV1 agonist 37 Soliris therapy 37 genotoxic stress 37 EGFR mutation positive 37 Kajang Prison 37 cystectomy 37 cisplatin 37 trastuzumab 37 CBM PSCs 37 MCyR 37 daunorubicin 37 postrelease supervision 37 HDAC inhibitors 37 refractory SCLC 37 antidiabetic therapy 37 Tumor regression 37 gemifloxacin 37 intravenous infusions 37 Liver transplantation 37 external beam radiotherapy 37 intensive statin therapy 37 vestibular schwannomas 37 CD4 + cells 37 EDSS scores 37 palliation 37 Nyepi 37 Pemetrexed 37 activating mutation 37 FUSILEV enhances 37 Adjuvant chemotherapy 37 xenograft models 37 paclitaxel cisplatin 37 flutamide 37 LWOP 37 complete cytogenetic 37 Pancreatic neuroendocrine tumors 37 Hurthle cell 37 bone metastasis 37 pelvic lymphadenectomy 37 concomitant medications 37 antitumour activity 37 CLL 37 deradicalization program 37 curability 37 rapid virological response 37 Chronic ITP 37 VT VF 37 dirucotide MBP# 37 paclitaxel Taxol R 37 convicts 37 rapid virologic response 37 CLARITY study 37 shortened telomeres 37 islet transplants 37 fibrinolytic 37 Peginterferon alfa 2b 37 gastrointestinal stromal tumor GIST 37 Cetuximab 37 CRp 37 adrenocortical cancer 37 non squamous histology 37 AML acute myeloid 37 metastatic renal cell 37 paclitaxel poliglumex 37 status epilepticus 37 Waldenstrom Macroglobulinemia 37 antitumor 37 mCRC patients 37 DTTOs 37 cells μL 37 CLL cells 37 mucosal healing 37 malignant transformation 37 maximal doses 37 dacarbazine 37 sentinel lymph node biopsy 37 #mg QD [002] 37 inducing apoptosis 37 refractory colorectal cancer 37 oxymorphone ER 37 EGFR mutations 37 Kerobokan jail 37 hepatic metastases 37 chemo radiotherapy 37 allogeneic hematopoietic stem cell 37 custodial sentence 37 cytarabine 37 #mg/day [002] 37 Abatacept 37 receiving VICTRELIS 37 bortezomib 37 solar keratoses 37 lymphopenia 37 refractory metastatic 37 temozolomide TMZ 37 stage IIIb IV 37 chemosensitivity 37 millennium plotter 36 transplantation HCT 36 hematological diseases 36 antiviral therapy 36 mesothelioma sufferers 36 E#F# 36 doxorubicin HCl 36 Vectibix monotherapy 36 chronic eosinophilic leukemia 36 VcMP 36 systemic corticosteroid 36 glioblastomas 36 Cethrin 36 adjuvant chemotherapy 36 bolus injections 36 paclitaxel chemotherapy 36 metastatic RCC 36 unfavorable cytogenetics 36 immunosuppressive medications 36 transarterial chemoembolization 36 TORISEL 36 Tysabri infusions 36 panobinostat 36 orphan designation 36 neoadjuvant chemotherapy 36 CD8 T cell 36 generalized tonic clonic seizures 36 neoadjuvant treatment 36 tyrosine kinase inhibitors 36 pazopanib 36 thymectomy 36 LHRH analogues 36 Neuromonics Tinnitus Treatment 36 virologic responses 36 #mg BID [003] 36 nephrotoxic 36 anti angiogenic therapies 36 anti angiogenic therapy 36 dyskeratosis congenita 36 imetelstat 36 leukaemic 36 EGF receptor 36 myelodysplastic syndromes MDS 36 disease progression 36 Myelodysplastic syndromes MDS 36 gemcitabine Gemzar 36 operable breast cancer 36 sustained virological response 36 interferon ribavirin 36 urothelial bladder cancer 36 TEMODAL 36 refractory CLL 36 alteplase 36 exacerbations 36 pediatric acute lymphoblastic 36 allogeneic transplant 36 MAGE A3 ASCI 36 parole eligibility 36 prednisone prednisolone 36 FOLFOX4 alone 36 Amrozi Imam Samudra 36 anti TNFs 36 hematologic toxicity 36 Abu Bakar Bashir 36 CD# mAb 36 parole 36 Rp#.# trillion [008] 36 polycystin 1 36 ALIMTA cisplatin 36 GIST tumors 36 blastic phase 36 nonmetastatic 36 Hurler syndrome 36 Torisel 36 viral kinetics 36 histologically confirmed 36 Hsp# inhibition 36 flavopiridol 36 nucleotide analogs 36 ispinesib administered 36 XZK 36 warfarin therapy 36 taxane therapy 36 Kepivance 36 anthracycline therapy 36 antiandrogen 36 remyelination 36 arsenic trioxide ATO 36 HERCEPTIN 36 biologic therapy 36 untreated multiple myeloma 36 unmutated 36 islet transplant 36 localized prostate 36 de ath 36 murderers rapists pedophiles 36 erlotinib Tarceva ® 36 Platinol ® cisplatin 36 interferon alfa 2b 36 rtPA 36 immunosuppressive drugs 36 fibrinolysis 36 MBCT 36 Pegasys plus Copegus 36 MIRCERA 36 revascularization procedure 36 epigenetic silencing 36 TroVax ® 36 recovery CRp 36 allogeneic HSCT 36 antibody cytokine 36 Artalyta 36 myeloproliferative diseases 36 abatacept 36 pamidronate 36 Imprisonment 36 insulin degludec 36 Aidil Fitri 36 systemic immunosuppressive 36 HER2 positive breast 36 combinability 36 neutrophil counts 36 cyclophosphamide 36 Hypertensive adverse reactions 36 oral prednisolone 36 Sheikh Fareed 36 hormonal therapy 36 grade gliomas 36 transgene expression 36 SCENESSE ® 36 FIRMAGON 36 acute lymphoblastic 36 ECD kidneys 36 serologically active systemic lupus 36 chemoradiation therapy 36 rearrest 36 cytopenias 36 K RAS 36 Nalini Murugan 36 malarial anemia 36 VELCADE melphalan 36 lenient sentences 36 myelofibrosis polycythemia vera 36 NLX P# 36 antithymocyte globulin 36 lymphocytic leukemia 36 4mg/kg 36 RhuDex R 36 Recurrences 36 Intravenous CP 36 Bali bombers 36 IL 1ß 36 activin 36 erlotinib 36 VIDAZA azacitidine 36 Mirza Nissar Hussain 36 clodronate 36 Conjugal visits 36 intravenous infusion 36 telaprevir dosed 36 EBRT 36 MGUS 36 chronic GVHD 36 Vidofludimus 36 medically inoperable 36 chemotherapies 36 TTF Therapy 36 neurologic sequelae 36 autoantibody positive 36 antiarrhythmic medications 36 antiretroviral naïve 36 immunological responses 36 clofarabine 36 Eliezer Zomer Ph.D. 36 P selectin 36 cabazitaxel 36 SNT MC# 36 mediated immunity 36 TNF alpha inhibitors 36 seliciclib 36 5-FU/LV 36 IVIg 36 parole revocations 36 tipranavir 36 haematological malignancies 36 immuno suppressive drugs 36 superficial basal cell carcinoma 36 Arikace 36 Militant cleric 36 hypomanic episodes 36 Orphan Drug Designation 36 XR NTX 36 platelet transfusion 36 immune thrombocytopenic purpura ITP 36 natalizumab 36 drug traffickers Schapelle Corby 36 retransplantation 36 gout flares 36 mutated K ras 36 HuLuc# 36 hematologic adverse 36 Bezielle 36 RF ablation 36 torsade de pointes 36 colorectal carcinoma 36 remand 36 Brain metastases 36 neoadjuvant radiation 36 zoledronic acid 36 hypoglycaemic episodes 36 renal transplants 36 Cutaneous T 36 Imatinib 36 posttransplant 36 EGFR targeting 36 folinic acid 36 undergoing CABG 36 psychodynamic psychotherapy 36 liver biopsies 36 surgical excision 36 cardiotoxic 36 ORAL HYCAMTIN 36 autoantibody levels 36 detectable HCV RNA 36 telomere shortening 36 gemcitabine Gemzar ® 36 renal tumors 36 MS relapses 36 darinaparsin 36 Exacerbations 36 ciclosporin 36 basal cell carcinoma BCC 36 imatinib 36 dose escalation phase 36 Raptiva r 36 EGFR expressing 36 seminomas 36 thrombocytosis 36 hematologic abnormalities 36 Palauan passports 36 chemotherapeutic 36 adalimumab Humira 36 erythropoietic agents 36 cutaneous squamous cell carcinoma 36 Cimzia TM 36 hypermethylation 36 cells PBMCs 36 microtubule targeting 36 EGFR tyrosine kinase inhibitors 36 Diffuse Large B 36 treating neuropathic pain 36 JAK2 V#F 36 Status epilepticus 36 acute promyelocytic leukemia 36 MGd 36 moderate renal insufficiency 36 GRNOPC1 contains 36 dosing interval 36 moderately emetogenic 36 remission CR 36 alpha interferons 36 pemetrexed 36 endothelin receptor antagonists 36 Dose limiting toxicities 36 IRESSA 36 HbF 36 antioxidant supplementation 36 hematological parameters 36 bone marrow suppression 36 aromatase inhibitor therapy 36 low dose cytarabine 36 PEGylated interferon beta 1a 36 concurrent sentences 36 habitual felons 36 imipenem 36 lamivudine 36 Doxil ® 36 nephrectomy 35 imatinib resistant 35 cytopenia 35 essential thrombocythemia 35 Disruptive Activities Act 35 PegIFN 35 immunosuppressant medication 35 drug DMARD 35 irinotecan chemotherapy 35 continuous intravenous infusion 35 INVEGA ® SUSTENNA TM 35 DMSA 35 aprepitant 35 unresectable stage 35 tolterodine 35 non squamous NSCLC 35 pneumonectomy 35 Caloric restriction 35 cleric Abu Bakar 35 HAART regimens 35 antiangiogenic therapy 35 riociguat 35 HNSCC 35 Orphan Drug designation 35 severe hypoglycaemia 35 rehearings 35 Decitabine 35 antiretroviral therapy 35 adjuvant endocrine therapy 35 Relapsing remitting MS 35 Vidaza azacitidine 35 ribavirin RBV 35 Vojo Vukovic MD Ph.D. 35 annualized relapse 35 glucocorticoids 35 novel VDA molecule 35 custodial remand 35 remands 35 LHRH agonist 35 chlorambucil 35 interferon IFN 35 rufinamide 35 Acute myeloid leukemia 35 Cisplatin 35 XGEVA 35 spontaneous remission 35 custirsen 35 lanthanum carbonate 35 Pegasys ® 35 pharmacokinetic characteristics 35 anaplastic thyroid carcinoma 35 moderate renal impairment 35 immunosuppressant medications 35 corticosteroid dexamethasone 35 metastatic bladder 35 Siswanto 35 IFN gamma 35 standard chemotherapy regimen 35 FOLPI 35 symptomatic intracranial hemorrhage 35 liver transplantation 35 Combination therapy 35 nilotinib 35 cyclophosphamide methotrexate 35 metastatic malignant 35 virologic failure 35 cefotaxime 35 chronic neuropathic pain 35 leukemia APL 35 Scale EDSS score 35 clinically meaningful improvements 35 discontinuations due 35 malignant gliomas 35 antiretroviral regimens 35 CYP #D# 35 randomized #:#:# 35 EBV infection 35 beta interferon 35 bcl 2 35 anti androgen 35 PSMA ADC 35 antidepressant pharmacotherapy 35 chemotherapy regimen 35 Gleevec imatinib mesylate 35 HER2 positive metastatic breast 35 papillary RCC 35 EGFR antibodies 35 endostatin 35 cART 35 intradermal injection 35 plus methotrexate 35 EDSS score 35 6 mercaptopurine 35 docetaxel Taxotere ® 35 nonmelanoma skin cancers 35 pulmonary dysfunction 35 cervical carcinoma 35 haematological 35 Q#IR 35 breast irradiation 35 ketogenic diet 35 systemic ALCL 35 efavirenz Sustiva 35 relapsing forms 35 radical prostatectomy RP 35 cetuximab 35 Bevacizumab Avastin 35 fasting plasma insulin 35 anaplastic 35 vismodegib 35 nonviolent offenses 35 Telintra 35 castration resistant 35 reconvicted 35 malignant lymphocytes 35 basal cell carcinomas 35 advanced hepatocellular carcinoma 35 trans retinoic acid 35 tumor regrowth 35 Fast Track designation 35 KRAS wild 35 immunomodulator 35 adjuvant therapies 35 antithrombotic therapy 35 clemency 35 BRAF V# mutation 35 tamibarotene 35 E1 INT TM 35 RBC transfusion 35 follicular non 35 NSW Corrective Services 35 autologous transplant 35 Essa Memon 35 CINV 35 circulating EPCs 35 autoinflammatory diseases 35 IDH mutations 35 anthracycline doses 35 neointimal hyperplasia 35 mentally ill offenders 35 induce apoptosis 35 electrical cardioversion 35 Infliximab 35 Arsenic trioxide 35 myeloablative therapy 35 Surgical excision 35 bony metastases 35 GISTs 35 FOLFOX chemotherapy 35 eculizumab therapy 35 carbidopa 35 basiliximab 35 QTc intervals 35 Fludarabine 35 BRAF mutation 35 gastrointestinal stromal tumors GIST 35 intravenous morphine 35 amrubicin 35 thalidomide dexamethasone 35 TGF b 35 tamoxifen Nolvadex ® 35 glioblastoma 35 immunosuppressive therapies 35 Introgen ADVEXIN 35 AChE inhibitors 35 intracranial hemorrhage ICH 35 relapsed APL 35 CR CRu 35 antitumor immunity 35 pathologic diagnosis 35 Rokhmin 35 Bali Kerobokan prison 35 antiangiogenic drugs 35 prognostically 35 activated partial thromboplastin 35 Basal cell 35 pegylated interferon 35 mg simvastatin 35 urate lowering therapy 35 Djaja 35 weekly subcutaneous injections 35 Follicular Lymphoma 35 Onconase 35 Anti retroviral therapy 35 Sandostatin LAR 35 CsA 35 aripiprazole 35 Zoledronic acid 35 romiplostim 35 Epileptic seizures 35 Kantoff 35 platelet inhibitor 35 pancytopenia 35 immunodeficiency disorders 35 chemotherapy gemcitabine 35 pouchitis 35 deletion 5q 35 Aptivus ® 35 Kinoid 35 glatiramer acetate Copaxone 35 relapsed CLL 35 OvaRex MAb 35 gemcitabine cisplatin 35 metastatic CRC 35 ASCT 35 treatment regimens 35 alpha 2A adrenoceptor 35 #mg/m# [001] 35 MDS AML 35 Acute Myeloid Leukaemia AML 35 thrombocytopenic 35 paclitaxel eluting stents 35 palifermin 35 Sustained virologic response 35 sentences commuted 35 CLL SLL 35 SPPs 35 effector T 35 bronchial thermoplasty 35 antitumor effects 35 COPD exacerbations 35 recurrences 35 undergo rigorous imprisonment 35 HBeAg seroconversion 35 interferon alpha 2b 35 Acute Myeloid Leukaemia 35 myelosuppression 35 thymic carcinoma 35 intradermal injections 35 CIMZIA ™ 35 HUMIRA adalimumab 35 FOLFIRI alone 35 golimumab CNTO 35 AVODART 35 RLAI 35 androgen therapy 35 carboplatin paclitaxel